SYNTAXIS
Syntaxis is committed to discovering, developing and commercialising novel therapeutics that enhance recovery of brain functions after stroke.
SYNTAXIS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2017-01-01
Address:
Lund, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.sinntaxis.com
Total Employee:
1+
Status:
Active
Contact:
46 7 07 18 89 30
Email Addresses:
[email protected]
Total Funding:
500 K SEK
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Google Font API Content Delivery Network LetsEncrypt SSL By Default HSTS Organization Schema Typekit
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Cellestia
Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression.
Cellics Therapeutics
Cellics is committed to saving lives and improving patients’ health using innovative biomimetic nanomedicines.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
LU Innovation
LU Innovation investment in Seed Round - Syntaxis
SmiLe Incubator
SmiLe Incubator investment in Grant - Syntaxis
Horizon 2020
Horizon 2020 investment in Grant - Syntaxis
Official Site Inspections
http://www.sinntaxis.com
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Syntaxis"
Sinntaxis
Sinntaxis will receive SEK 900,000 from Vinnova’s call for proposals for “Innovative Startups step 2 autumn 2020” to continue to prepare for the planned clinical proof of concept trial. Stroke is …See details»
Sinntaxis Company Profile 2024: Valuation, Funding & Investors
Sinntaxis General Information Description. Operator of a biotechnology company intended to develop novel therapeutics for stroke recovery. The company patients negative allosteric …See details»
Sinntaxis - LinkedIn
Sinntaxis was founded 2017 by scientists at Lund University and LU Holding AB. The company is managed by a team with vast experience in neuroscience/stroke research and pharmaceutical …See details»
Syntaxis - Crunchbase Company Profile & Funding
Organization. Syntaxis . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Syntaxis is committed to discovering, developing …See details»
Sinntaxis - Products, Competitors, Financials, Employees, …
Sinntaxis is a biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for stroke recovery. Use the CB Insights Platform to …See details»
Sinntaxis | LU Innovation
The company Sinntaxis AB is set out to develop a drug that can improve the rehabilitation of this patient group. Sinntaxis AB's website . Sinntaxis Developing novel therapeutics that enhance …See details»
Sinntaxis - Overview, News & Competitors | ZoomInfo.com
Sinntaxis. Business Services · Sweden · <25 Employees. Sinntaxis was founded 2017 by scientists at Lund University and LU Holding AB. The company is managed by a team with …See details»
Sinntaxis Company Profile - Office Locations, Competitors ... - Craft
Sinntaxis has 5 employees at their 1 location. See insights on Sinntaxis including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Sinntaxis - Company Profile - Tracxn
Sinntaxis - Developer of small molecule based therapeutics for the treatment of stroke recovery. Raisedfunding over 2 rounds from 4 investors. Sinntaxis has 34 competitors.See details»
Sinntaxis AB - Drug pipelines, Patents, Clinical trials - Synapse
Jul 8, 2023 Explore Sinntaxis AB with its drug pipeline, therapeutic area, technology platform, .See details»
Sinntaxis - VentureRadar
Similar Companies: Sun BioPharma USA Privately Held Sun BioPharma is developing small-molecule pharmaceuticals consisting of novel polyamine analogues and metal chelators, and …See details»
Sinntaxis - Raised Funding from 4 investors - Tracxn
Sep 22, 2024 Sinntaxis has raised funding over 2 rounds from 4 investors. Investors include EIC Fund, Vinnova and 2 others. Their latest funding round was of $105K on Nov 25, 2020 .See details»
☑️Sinntaxis — Consulting Organization from Sweden, experience …
Sinntaxis — Consulting Organization from Sweden, has experience with Horizon 2020 (2014 - 2020), it`s involved in Health, Research sectorsSee details»
Repurposed drug offers hope for those recovering from stroke
Dec 13, 2019 Later, during stroke recovery, patients may also receive rehabilitation therapies but these are often insufficient and result in limited effect. There are currently no medical …See details»
Sinntaxis
Mar 12, 2018 Sinntaxis Sinntaxis. Sinntaxis About us Research & Development News Management & board Contact Sinntaxis March 12, 2018. Tadeusz Wieloch. Press release . …See details»
Sinntaxis secures option for Phase 2 -ready molecule helping
Oct 12, 2018 Sinntaxis announces today that it has entered into an option agreement with Acturum for an exclusive license to drug candidate AZD2066 for the development of a …See details»
Sinntaxis secures option on ex-AstraZeneca drug - NLS
Oct 11, 2018 Sinntaxis has signed an option deal with Acturum regarding an exclusive license for the drug candidate AZD2066. The phase II ready molecule (mGluR5 antagonist) could …See details»
Sinntaxis bags option on ex-AstraZeneca mGluR5 antagonist
Oct 9, 2018 Sinntaxis has secured an option on an ex-AstraZeneca drug. AstraZeneca dropped mGluR5 antagonist AZD2066 after getting a look at midphase data, but Sinntaxis thinks it can …See details»
mGluR5 NAM modulators (Sinntaxis) - Drug Targets, Indications, …
Literatures (Medical) associated with mGluR5 NAM modulators (Sinntaxis) 21 Sep 2016 · The Journal of neuroscience : the official journal of the Society for Neuroscience Q1 · MEDICINE …See details»
Working at Sintaxis - Glassdoor
Glassdoor gives you an inside look at what it's like to work at Glassdoor, including salaries, reviews, office photos, and more. This is the Glassdoor company profile.See details»